Abuse drugs and derivatives

(1R,2S)-(-)-Ephedrine

(1R,2S)-(-)-Ephedrine hydrochloride

(1R,2S)-(-)-Ephedrine hydrochloride, 1000µg/ml in MeOH, 1ml

(1R,2S)-(-)-Ephedrine hydrochloride, 1g

(1R,2S)-(-)-Ephedrine-d6 hydrochloride (dimethyl-d

(1R,2S)-(-)-Ephedrine-d6 hydrochloride (dimethyl-d

(1R,2S)-(-)-Ephedrine, 1g

(1R,2S)-(-)-N-Methylephedrine

(1R,2S)-(-)-N-Methylephedrine

(1R,2S)-(-)-N-Methylephedrine

(1R,2S)-(-)-Norephedrine

(1R,2S)-(-)-Norephedrine

(1S,2R)-(+)-Ephedrine hydrochloride

(1S,2R)-(+)-Ephedrine hydrochloride

(1S,2R)-(+)-Ephedrine hydrochloride

(1S,2R)-(+)-Ephedrine-d3 hydrochloride

(1S,2R)-(+)-Ephedrine-d3 hydrochloride(N-methyl-d3

(1S,2S)-(+)-Pseudoephedrine

(1S,2S)-(+)-Pseudoephedrine

(1S,2S)-(+)-Pseudoephedrine-d3 HCl (N-methyl-d3)

(1S,2S)-(+)-Pseudoephedrine, 100mg

(2-Iodophenyl)-[1-[(1-methyl-2-piperidinyl)methyl]

(2-Iodophenyl)-[1-[(1-methyl-2-piperidinyl)methyl]

(2-Methoxyphenyl)-(1-pentyl-1H-indol-3-yl)methanon